PT  - JOURNAL ARTICLE
AU  - Francesca Santamaria
AU  - Silvia Montella
AU  - Virginia Mirra
AU  - Sara De Stefano
AU  - Generoso Andria
AU  - Giancarlo Parenti
TI  - Respiratory manifestations in patients with inherited metabolic diseases
AID  - 10.1183/09059180.00008012
DP  - 2013 Dec 01
TA  - European Respiratory Review
PG  - 437--453
VI  - 22
IP  - 130
4099  - http://err.ersjournals.com/content/22/130/437.short
4100  - http://err.ersjournals.com/content/22/130/437.full
SO  - EUROPEAN RESPIRATORY REVIEW2013 Dec 01; 22
AB  - Growing evidence indicates that inherited metabolic diseases are increasingly being recognised. Life expectancy for many patients is progressively improving because new therapeutic strategies are available. Because most inherited metabolic diseases are systemic disorders, virtually all organs may be involved. Respiratory disease complicates the management of several inherited metabolic diseases, either at presentation or as late-onset features. This review will describe the most exemplary respiratory manifestations of inherited metabolic diseases in childhood and adulthood. Since airways disease worsens the morbidity of many inherited metabolic disorders, leading to increased hospitalisations, mortality and overall healthcare costs, respiratory manifestations of inherited metabolic diseases need to be carefully recognised and treated. All patients with inherited metabolic disease and suspected airway disease should undergo a detailed diagnostic work-up. Current treatments for several inherited metabolic diseases (including enzyme replacement therapy, substrate reduction, bone marrow transplantation, or even more innovative strategies such as pharmacological chaperone or gene therapies) may provide significant benefits for associated respiratory disease. The integration of several specialists dedicated to airway disease management in a multidisciplinary team is essential to provide the most appropriate care to children and adults with inherited metabolic disease.